Written by [author]. Reviewed by [reviewer].
Updated . How we research and review.
Short answer
What is CJC-1295 + Ipamorelin?
CJC-1295 with ipamorelin is a single lyophilised vial that holds two research compounds: CJC-1295 (no DAC form, as labelled by the supplier) and ipamorelin. The amount of each compound in the vial is reported on its batch certificate.
What is in each CJC-1295 + Ipamorelin vial?
| STRENGTH | FORM | PRICE | CERTIFICATE |
|---|---|---|---|
| 10mg | Lyophilised powder | A$108 | Pending |
Which compounds are in CJC-1295 + Ipamorelin?
| COMPOUND | CLASS | AUSTRALIA | WADA 2026 |
|---|---|---|---|
| CJC-1295 | Synthetic GHRH(1-29) analogue carrying a drug affinity complex (maleimidopropionyl-lysine) designed to bind albumin covalently | Schedule 4 | S2.2.4 |
| Ipamorelin | Synthetic pentapeptide growth hormone secretagogue (ghrelin receptor agonist) | Schedule 4 | S2.2.4 |
Does CJC-1295 + Ipamorelin cost less than buying each compound?
The CJC-1295 + Ipamorelin vial is A$108. The smallest vial of each component bought separately totals A$153. The amount of each compound in the blend is on its certificate [pending], so compare the price per milligram once it is published.
| BOUGHT SEPARATELY | STRENGTH | PRICE |
|---|---|---|
| CJC-1295 | 10mg | A$85 |
| Ipamorelin | 10mg | A$68 |
| Total | A$153 | |
| CJC-1295 + Ipamorelin vial | 10mg | A$108 |
What has research on CJC-1295 + Ipamorelin examined?
No published study of the CJC-1295 + Ipamorelin blend was found. The research below covers each component on its own.
CJC-1295: CJC-1295 was examined in two randomized, placebo-controlled, ascending-dose trials in healthy adults and a further pharmacodynamic study (2006), and in rodent models including GHRH-knockout mice. Much later literature concerns anti-doping detection. Ipamorelin: Ipamorelin was characterised in cell and animal studies (e.g. rat pituitary cells, swine, rats) in the late 1990s. Human work includes a pharmacokinetic-pharmacodynamic study in healthy volunteers and a randomized phase II proof-of-concept trial in postoperative ileus.
What adverse events have studies of CJC-1295 + Ipamorelin reported?
CJC-1295: In two randomized, placebo-controlled, ascending-dose trials in healthy adults aged 21-61 (28 and 49 days), no serious adverse reactions were reported (PMID 16352683). The abstract lists no specific non-serious adverse events. No other human study reporting adverse events was found. Ipamorelin: In a phase 2 placebo-controlled trial in 114 bowel-resection patients given intravenous ipamorelin for up to 7 days, treatment-emergent adverse events occurred in 87.5% on ipamorelin and 94.8% on placebo (PMID 25331030). No other human study reporting adverse events was found.
These findings describe the people or animals in each study. The sources list gives every PubMed record.
How do you reconstitute and store CJC-1295 + Ipamorelin?
Store the sealed vial frozen (about -20 degrees Celsius), dry and away from light until it is reconstituted.
After reconstitution with a sterile solvent, keep the solution at 2 to 8 degrees Celsius and avoid repeated freezing and thawing. Record the solvent, volume and date on the vial label.
BAC Water is the usual laboratory solvent. Dilute acetic acid is an alternative for peptides that dissolve poorly in water. The reconstitution guide and storage guide cover laboratory handling.
| STATE | TEMPERATURE | NOTES |
|---|---|---|
| Sealed vial | -20 °C | Dry and dark. Keeps to the label date. |
| Reconstituted | 2 to 8 °C | Sterile technique. Avoid repeat freeze and thaw. |
| In transit | Cold pack | Refrigerate or freeze on arrival. |
Is CJC-1295 + Ipamorelin legal to buy in Australia?
CJC-1295 is listed in Schedule 4 of the Poisons Standard (prescription only). It is also listed in Appendix D clause 5, which makes possession without authority an offence. Source: the June 2026 Poisons Standard instrument (F2026L00633).
Ipamorelin is listed in Schedule 4 of the Poisons Standard (prescription only). It is also listed in Appendix D clause 5, which makes possession without authority an offence. Source: the June 2026 Poisons Standard instrument (F2026L00633).
WADA's 2026 Prohibited List prohibits CJC-1295 at all times, under class S2.2.4.
WADA's 2026 Prohibited List prohibits Ipamorelin at all times, under class S2.2.4.
Are peptides legal in Australia?How fast does CJC-1295 + Ipamorelin ship?
Orders placed before [cut-off] leave Western Australia the same business day with tracking, by [carrier]. Delivery estimates for each state are on the shipping page.
How does CJC-1295 + Ipamorelin compare?
CJC-1295 + Ipamorelin questions
What adverse events have studies of CJC-1295 + Ipamorelin reported?
CJC-1295: In two randomized, placebo-controlled, ascending-dose trials in healthy adults aged 21-61 (28 and 49 days), no serious adverse reactions were reported (PMID 16352683). The abstract lists no specific non-serious adverse events. No other human study reporting adverse events was found. Ipamorelin: In a phase 2 placebo-controlled trial in 114 bowel-resection patients given intravenous ipamorelin for up to 7 days, treatment-emergent adverse events occurred in 87.5% on ipamorelin and 94.8% on placebo (PMID 25331030). No other human study reporting adverse events was found.
What has research on CJC-1295 + Ipamorelin examined?
No published study of the CJC-1295 + Ipamorelin blend was found. Research on each component: CJC-1295: CJC-1295 was examined in two randomized, placebo-controlled, ascending-dose trials in healthy adults and a further pharmacodynamic study (2006), and in rodent models including GHRH-knockout mice. Much later literature concerns anti-doping detection. Ipamorelin: Ipamorelin was characterised in cell and animal studies (e.g. rat pituitary cells, swine, rats) in the late 1990s. Human work includes a pharmacokinetic-pharmacodynamic study in healthy volunteers and a randomized phase II proof-of-concept trial in postoperative ileus.
Which compounds are in CJC-1295 + Ipamorelin?
CJC-1295 + Ipamorelin holds CJC-1295 and Ipamorelin. The batch certificate reports the measured amount of each.
Does CJC-1295 + Ipamorelin cost less than buying each compound?
The CJC-1295 + Ipamorelin vial costs A$108. Buying the smallest vial of each component separately costs A$153. The amount of each compound in the blend is on its certificate [pending], so compare the price per milligram once it is published.
Is CJC-1295 + Ipamorelin sold for human use?
No. CJC-1295 + Ipamorelin is sold for laboratory research use only. It is not a medicine and is not for human or veterinary use.
Where is CJC-1295 + Ipamorelin shipped from?
Orders ship tracked from Western Australia. Orders placed before [cut-off] leave the same business day. Delivery estimates by state are on the shipping page.
Is CJC-1295 + Ipamorelin a prescription medicine in Australia?
CJC-1295 is listed in Schedule 4 of the Poisons Standard (prescription only). It is also listed in Appendix D clause 5, which makes possession without authority an offence. Ipamorelin is listed in Schedule 4 of the Poisons Standard (prescription only). It is also listed in Appendix D clause 5, which makes possession without authority an offence. Peptides Collective sells the blend for laboratory research use only.
Can I buy each compound in CJC-1295 + Ipamorelin separately?
Yes. CJC-1295 (from A$85), Ipamorelin (from A$68) are each sold on their own, with their own certificates.
How is CJC-1295 + Ipamorelin reconstituted?
One reconstitution covers every compound in the vial. BAC Water is the usual laboratory solvent. Record the solvent, volume and date on the vial label.
How long does an unopened CJC-1295 + Ipamorelin vial keep?
A sealed vial of lyophilised powder keeps to the date on its label when stored frozen, dry and dark. Once reconstituted, keep the solution at 2 to 8 degrees Celsius and record the date on the label.
Is CJC-1295 + Ipamorelin tested as one batch?
Yes. The blended vial is tested as one batch. The certificate reports identity and content for every compound in the vial.
How do I match my vial to its certificate?
Find the batch number printed on the vial label, then search it in the certificate library. The result shows the lab, method, purity and test date for that batch.
Sources
- 1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism, 2006. PMID 16352683.
- 2. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of clinical endocrinology and metabolism, 2006. PMID 17018654.
- 3. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American journal of physiology. Endocrinology and metabolism, 2006. PMID 16822960.
- 4. Ipamorelin, the first selective growth hormone secretagogue. European journal of endocrinology, 1998. PMID 9849822.
- 5. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 1999. PMID 10373343.
- 6. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical research, 1999. PMID 10496658.
- 7. Poisons Standard, June 2026 instrument (F2026L00633). Federal Register of Legislation.
- 8. World Anti-Doping Code, 2026 Prohibited List. WADA.
